Dechra Pharmaceuticals PLC
19 September 2005
Dechra Pharmaceuticals PLC ('the Company')
Holding(s) in Company
The Company was notified by Barclays PLC that through the legal entities of
Barclays Global Investors Ltd, Barclays Capital Securities Ltd, Barclays Life
Assurance Co Ltd and Gerrard Ltd, Barclays PLC has a notifiable interest in
2,052,147 ordinary shares of 1p each in the Company ('Ordinary Shares'),
representing approximately 4.01 per cent. of the Company's issued ordinary share
capital. These Ordinary Shares are registered as follows:
Registered Holder Ordinary Shares
Barclays Capital Nominees Limited 571,658
Chase Nominees Ltd a/c 16376 28,830
Chase Nominees Ltd a/c 21359 114,544
Chase Nominees Ltd a/c 28270 35,282
Chase Nominees Ltd a/c 28270 22,282
JP Morgan (BGI Custody) a/c 16341 56,561
JP Morgan (BGI Custody) a/c 16341 31,935
JP Morgan (BGI Custody) a/c 16344 21,055
JP Morgan (BGI Custody) a/c 16345 34,675
JP Morgan (BGI Custody) a/c 16400 386,797
JP Morgan (BGI Custody) a/c 16480 467,661
JP Morgan (BGI Custody) a/c 16482 250,007
JP Morgan (BGI Custody) a/c 18409 29,412
R C Greig Nominees Limited a/c AK1 1,448
Total 2,052,147
19 September 2005
This information is provided by RNS
The company news service from the London Stock Exchange
ZM
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.